Cytotoxic and immune-mediated killing of human colorectal cancer by reovirus-loaded blood and liver mononuclear cells - Test2 - elhamkhani - TriplyDB

Cytotoxic and immune-mediated killing of human colorectal cancer by reovirus-loaded blood and liver mononuclear cells

Cytotoxic and immune-mediated killing of human colorectal cancer by reovirus-loaded blood and liver mononuclear cells

http://www.wikidata.org/entity/Q37477574

about

Evidence for Oncolytic Virotherapy: Where Have We Got to and Where Are We Going?Potential for Improving Potency and Specificity of Reovirus Oncolysis with Next-Generation Reovirus Variants Trial Watch:: Oncolytic viruses for cancer therapy Trial Watch-Oncolytic viruses and cancer therapy Maraba MG1 virus enhances natural killer cell function via conventional dendritic cells to reduce postoperative metastatic disease Oncolytic reovirus in canine mast cell tumor.Lymphokine-activated killer and dendritic cell carriage enhances oncolytic reovirus therapy for ovarian cancer by overcoming antibody neutralization in ascites Immune cells: more than simple carriers for systemic delivery of oncolytic viruses.A phase I trial and viral clearance study of reovirus (Reolysin) in children with relapsed or refractory extra-cranial solid tumors: a Children's Oncology Group Phase I Consortium report Cytokine conditioning enhances systemic delivery and therapy of an oncolytic virus.The combination of intravenous Reolysin and gemcitabine induces reovirus replication and endoplasmic reticular stress in a patient with KRAS-activated pancreatic cancer.Oncolytic reovirus enhances rituximab-mediated antibody-dependent cellular cytotoxicity against chronic lymphocytic leukaemia.The oncolytic virus, pelareorep, as a novel anticancer agent: a review.Oncolytic vaccinia virus as a vector for therapeutic sodium iodide symporter gene therapy in prostate cancer.Enhancement of antibody-dependent cell mediated cytotoxicity: a new era in cancer treatment.Cell carriers for oncolytic viruses: current challenges and future directions.Controlled infection with a therapeutic virus defines the activation kinetics of human natural killer cells in vivo.Review: Oncolytic virotherapy, updates and future directions.Oncolytic reovirus therapy: Pilot study in dogs with spontaneously occurring tumours.A Phase II Study of Pelareorep (REOLYSIN®) in Combination with Gemcitabine for Patients with Advanced Pancreatic Adenocarcinoma.

P2860

Q26775030-65F9BEFF-3CD4-417E-AAAA-751531B5D2CF Q26775033-7C21DB82-7593-45F5-8345-8C6225348DE5 Q27021951-CF701D67-37F5-4F59-8D2B-CC8734440299 Q28072347-A5932552-29E1-46B1-806B-FCDE4509FE6E Q33870670-E10571B9-A8A3-47FA-A8C9-44BF3B1D26D3 Q35000631-52D03E65-D4AB-4CBD-9EA5-F4A6E7FECB73 Q35061974-679E50F0-F645-4802-BE80-F57369797CF6 Q35162284-4BB35E3D-A61B-44D3-B22A-003170314CD9 Q35224368-3121BAD0-4D27-44C6-AE63-883C6EC2EB72 Q35596563-C597BB58-A38C-4252-BC07-F615050053FE Q35686522-BCBF3D57-835F-46F5-92D8-0525A548C586 Q35812675-414D993F-619E-4194-BCA1-EF17104D4F00 Q38360781-41F8FF81-B8E7-409E-93BC-9010CBB7A065 Q38799217-B71C31F3-FED5-4D33-A3A8-64378D4064DB Q38912287-AB451A51-04D8-4179-83F7-47CFBC6DE973 Q38924531-0257C924-8079-468F-B0BD-E996B1428DA4 Q41621228-674F3CF1-5F52-47FD-803D-0963BE27EC89 Q47160989-1E9C137B-3D9A-439F-B8ED-392EC871274C Q47596708-A9A3C3BD-8198-4A41-A4E6-7202D1FEAF1D Q55464219-947DAF7F-FD00-4591-93F8-926B96C2C18A

P2860

Cytotoxic and immune-mediated killing of human colorectal cancer by reovirus-loaded blood and liver mononuclear cells

http://www.wikidata.org/entity/Q37477574

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Cytotoxic and immune-mediated ...... od and liver mononuclear cells

@en

Cytotoxic and immune-mediated ...... od and liver mononuclear cells

@en-gb

Cytotoxic and immune-mediated ...... d and liver mononuclear cells.

@nl

type

label

Cytotoxic and immune-mediated ...... od and liver mononuclear cells

@en

Cytotoxic and immune-mediated ...... od and liver mononuclear cells

@en-gb

Cytotoxic and immune-mediated ...... d and liver mononuclear cells.

@nl

prefLabel

Cytotoxic and immune-mediated ...... od and liver mononuclear cells

@en

Cytotoxic and immune-mediated ...... od and liver mononuclear cells

@en-gb

Cytotoxic and immune-mediated ...... d and liver mononuclear cells.

@nl

P1433

Q37477574-978B260B-5740-4B3D-ADF9-16454FA34D67

P1476

Q37477574-C29AF8D1-221B-4012-8422-2C57D3217EAE

P2093

Q37477574-27674831-70AF-4E69-B360-69E7D7BCB918

Q37477574-57A32A48-EB22-4BF9-A6FB-E26762914DBE

Q37477574-776C9E68-31B0-4DDD-AFF3-10F27A94B825

Q37477574-88B1F6BC-35F3-4A33-A20D-8DF0DA7B6931

Q37477574-A342C1F3-348D-440D-8DEC-511B13C3AE8F

Q37477574-ADC84BBF-A51A-4341-8E80-330CFBE04FEC

Q37477574-D9EBBE25-DB88-4B7F-B6B9-AD3113BA58B7

Q37477574-EC725594-E0AD-4DC0-B39D-0C60C44B70BD

P2860

Q37477574-01A840D4-93EF-4B6F-8173-B51F638993E7

Q37477574-041C2C78-F196-447C-A70B-845BBC05E12E

Q37477574-067AA840-F452-45C4-A596-155224F37B85

Q37477574-07254826-3A45-43B1-9C64-1005131C6F21

Q37477574-0A90F5C5-4349-42D6-89BD-C1BBDCE3F833

Q37477574-0CA04FED-9B60-498B-981A-C1E9A67DD471

Q37477574-0D2667D7-A18F-4AA3-8987-3A586E41F689

Q37477574-16DCC753-BAAF-40B1-A19C-EECCCD0238E6

Q37477574-1BDB0554-220B-451F-91A0-C92D218F49F5

Q37477574-2CEFF28F-EEDA-4810-9841-F621F1365055

P304

Q37477574-C87124E5-D241-4A3B-863C-0442064C90E0

P31

Q37477574-978F7BC9-09E6-4912-A3E1-59E9AAE62EC4

P356

Q37477574-951D648C-83C2-4FF5-96A2-3622E850283E

P433

Q37477574-D7D5E700-C6E6-46AD-B645-6B347F891F8C

P478

Q37477574-CD80BA27-DFAC-4ACE-8D7B-FA5CE61B1266

P50

Q37477574-68AE8E2F-070F-4020-B175-1FF69F97D528

Q37477574-8EA4C2BB-2113-4F44-90CF-D916105B473B

Q37477574-E3BA2251-6ABB-4B3B-B403-591B0BEC6E87

Q37477574-E4FA4824-46CE-49DF-8C89-D8A8C28429E7

P577

Q37477574-4E665013-725E-4846-8CEE-CEF4ED1681A1

P5875

Q37477574-8DF99E51-1ABE-48C3-8D3D-6D66BADCB876

P698

Q37477574-53C6D4F4-C497-43A8-B837-3ACB6C2E257E

P921

Q37477574-72ACE81D-7D3A-4404-8B24-FD472F29FB8E

Q37477574-95E86818-2885-4961-9EF1-36FE57786586

P932

Q37477574-F4F9B82A-059B-4921-966C-A45E1D578C91

P356

P1433

International Journal of Cancer

P1476

Cytotoxic and immune-mediated ...... od and liver mononuclear cells

@en

P2093

Alan A Melcher

http://www.w3.org/2001/XMLSchema#string

Fiona Errington-Mais

http://www.w3.org/2001/XMLSchema#string

Hardev Pandha

http://www.w3.org/2001/XMLSchema#string

Kevin J Harrington

http://www.w3.org/2001/XMLSchema#string

Matt Coffey

http://www.w3.org/2001/XMLSchema#string

Richard Vile

http://www.w3.org/2001/XMLSchema#string

Robert A Adair

http://www.w3.org/2001/XMLSchema#string

Sheila Fraser

http://www.w3.org/2001/XMLSchema#string

P2860

Cell carriage, delivery, and selective replication of an oncolytic virus in tumor in patients

Clinical trials with oncolytic reovirus: moving beyond phase I into combinations with standard therapeutics.

Junction adhesion molecule is a receptor for reovirus

Genetic and Chemical Models of Colorectal Cancer in Mice.

Recent clinical experience with oncolytic viruses.

Characterization of the adaptive and innate immune response to intravenous oncolytic reovirus (Dearing type 3) during a phase I clinical trial.

Reovirus-induced apoptosis: A minireview.

Cross-talk between dendritic cells and natural killer cells in viral infection.

Innate immunity in the liver.

Drug evaluation: Reolysin--wild-type reovirus as a cancer therapeutic.

P304

2327-2338

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/IJC.27918

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

132

http://www.w3.org/2001/XMLSchema#string

P50

Giles J. Toogood

P577

2012-11-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232744290

http://www.w3.org/2001/XMLSchema#string

P698

23114986

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

P932

3891508

http://www.w3.org/2001/XMLSchema#string